Matching mutations in tumours to precision medicine improves survival
2 Jun 2018
Matching mutations in tumours to precision medicine improves survival
Atezolizumab with chemotherapy improves PFS in squamous NSCLC
Taselisib with fulvestrant slows growth of advanced breast cancer
Editor’s Choice for May 2018
Passage of treatments at the blood-brain barrier
Incorporating biomarkers into clinical trial design
Dealing with peripheral neuropathic pain in multiple myeloma
Managing infections in patients with multiple myeloma
Clinical management of plasma cell leukaemia
Editor's Choice for April 2018
Dose escalation of durvalumab with tremelimumab for metastatic urothelial cancer
Safety indications in mouse models treated with full doses of MEK inhibitors and SHP099